Try our beta test site

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cellerix ( TiGenix S.A.U. )
ClinicalTrials.gov Identifier:
NCT01663116
First received: August 5, 2011
Last updated: March 5, 2013
Last verified: February 2013